जापान - अंग्रेज़ी - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - theophylline - white tablet, diameter: 6.0 mm, thickness: 3.7 mm

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - theophylline 125mg;  ; theophylline 125mg - modified release tablet - 125 mg - active: theophylline 125mg   excipient: cellacefate lactose monohydrate magnesium stearate active: theophylline 125mg excipient: guar gum magnesium stearate

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - theophylline 350mg;  ; theophylline 350mg - modified release tablet - 350 mg - active: theophylline 350mg   excipient: cellacefate lactose monohydrate magnesium stearate active: theophylline 350mg excipient: guar gum magnesium stearate

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - theophylline 500mg;  ; theophylline 500mg - modified release tablet - 500 mg - active: theophylline 500mg   excipient: cellacefate lactose monohydrate magnesium stearate active: theophylline 500mg excipient: guar gum magnesium stearate

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - theophylline - prolonged-release tablet - 200 milligram(s) - xanthines; theophylline

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - theophylline - prolonged-release tablet - 300 milligram(s) - xanthines; theophylline

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mundipharma pharmaceuticals limited - theophylline - prolonged-release tablet - 400 milligram(s) - xanthines; theophylline

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

monarch pharmaceuticals, inc. - theophylline, anhydrous (unii: 0i55128jyk) (theophylline - unii:c137dtr5rg) - tablet - 300 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. quibron® -t accudose® tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

ennogen healthcare (europe) limited - theophylline - prolonged-release tablet - xanthines; theophylline